STOCK TITAN

Nature's Miracle Holding Inc. ("NMHI") Raised $2 Million Through Convertible Preferred Shares Issuance

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Nature's Miracle Holding (OTCQB:NMHI) has secured a $2 million investment through a convertible preferred shares agreement with an Asia-based private investor. The company issued 2,000 Series D Preferred Shares convertible at $0.1180 per share, based on the September 18, 2025 closing price.

The investment will be received in two tranches: an initial $500,000 received on September 19, 2025, and a subsequent $1.5 million to be closed before November 15, 2025. The proceeds will be utilized for working capital purposes.

Nature's Miracle Holding (OTCQB:NMHI) ha assicurato un investimento di $2 milioni tramite un accordo su azioni privilegiate convertibili con un investitore privato con sede in Asia. La società ha emesso 2.000 azioni privilegiate di Serie D convertibili al prezzo di $0,1180 per azione, basato sul prezzo di chiusura del 18 settembre 2025. L'investimento sarà ricevuto in due trance: la prima di $500.000 entro il 19 settembre 2025, e una successiva di $1,5 milioni da chiudere entro il 15 novembre 2025. I proventi saranno destinati a liquidità operativa.
Nature's Miracle Holding (OTCQB: NMHI) ha asegurado una inversión de $2 millones a través de un acuerdo de acciones preferentes convertibles con un inversor privado con sede en Asia. La empresa emitió 2.000 acciones preferentes de Serie D convertibles a $0,1180 por acción, según el precio de cierre del 18 de septiembre de 2025. La inversión se recibirá en dos tramos: un inicial de $500,000 recibido el 19 de septiembre de 2025, y un tramo posterior de $1,5 millones que se cerrará antes del 15 de noviembre de 2025. Los fondos se destinarán a necesidades de capital de trabajo.
Nature's Miracle Holding (OTCQB: NMHI)는 아시아에 본사를 둔 사모 투자자로부터 컨버터블 우선주 협약을 통해 $2백만의 투자를 확보했습니다. 회사는 시리즈 D 우선주 2,000주주당 $0.1180에 전환 가능하도록 발행했으며, 이는 2025년 9월 18일 종가를 기준으로 합니다. 투자는 두 차례에 걸쳐 이루어지며, 첫 번째로 $500,000가 2025년 9월 19일에 수령되고, 이후 $1.5백만이 2025년 11월 15일 이전에 마감될 예정입니다. 자금은 운전자본으로 사용될 예정입니다.
Nature's Miracle Holding (OTCQB : NMHI) a sécurisé un investissement de 2 millions de dollars via un accord d'actions privilégiées convertibles avec un investisseur privé basé en Asie. La société a émis 2 000 actions privilégiées de série D convertibles à $0,1180 par action, sur la base du cours de clôture du 18 septembre 2025. L'investissement sera reçu en deux tranches : une tranche initiale de $500 000 le 19 septembre 2025 et une tranche subséquente de $1,5 million à clôturer avant le 15 novembre 2025. Les fonds seront destinés au fonds de roulement.
Nature's Miracle Holding (OTCQB: NMHI) hat eine Investition von 2 Millionen US-Dollar durch eine Umwandlungs-prioritätsaktien-Vereinbarung mit einem in Asien ansässigen privaten Investor gesichert. Das Unternehmen hat 2.000 Series-D-Privataktien ausgegeben, die zu $0,1180 pro Aktie wandelbar sind, basierend auf dem Schlusskurs vom 18. September 2025. Die Investition wird in zwei Tranchen erfolgen: eine anfängliche Tranche von $500,000 wird am 19. September 2025 erhalten, und eine anschließende von $1,5 Millionen, die vor dem 15. November 2025 abgeschlossen wird. Die Mittel dienen dem Betriebskapital.
Nature's Miracle Holding (OTCQB: NMHI) أمنت استثماراً قدره $2 مليون من خلال اتفاق أسهم ممتازة قابلة للتحويل مع مستثمر خاص مقره في آسيا. أصدرت الشركة 2,000 سهم ممتاز من الفئة D قابلة للتحويل بسعر $0.1180 للسهم، استناداً إلى سعر الإغلاق في 18 سبتمبر 2025. سيتم استلام الاستثمار على دفعتين: دفعة ابتدائية قدرها $500,000 ستُستلم في 19 سبتمبر 2025، ودفعة تالية قدرها $1.5 مليون ستُغلق قبل 15 نوفمبر 2025. ستستخدم العائدات كسيولة تشغيلية.
Nature's Miracle Holding (OTCQB: NMHI) 已通过与一家亚洲私募投资者签署的可转换优先股协议,获得了< b>$200万美元投资。公司发行了< b>2,000 股D系列优先可转换股,按< b>$0.1180/股的价格转换,基于2025年9月18日收盘价。投资将分两笔到账:第一笔为< b>$500,000,于2025年9月19日收到,随后在< b>2025年11月15日前完成的第二笔将为< b>$1.5百万。所得资金将用于营运资金用途。
Positive
  • Secured $2 million in new funding through preferred shares
  • Investment structured in two tranches, with $500,000 already received
Negative
  • Potential dilution for existing shareholders through future conversion of preferred shares

ONTARIO, Calif., Sept. 24, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI or "Nature's Miracle") announces that it has signed a $2 million convertible preferred investment agreement with an Asia-based private investor. Nature's Miracle Holding Inc. issued 2,000 Series D Preferred Shares which can be converted into the Company's common stocks at $0.1180 per share (the closing price on September 18th, 2025).  The initial tranche of $500,000 was received by Nature's Miracle on September 19, 2025 and the subsequent tranche of $1.5 million will close before November 15, 2025. The proceeds of the Convertible Preferred Share will be used for working capital.

(PRNewsfoto/Nature's Miracle Holding Inc.)

About Nature's Miracle Holding Inc.

Nature's Miracle Holding Inc. (OTCQB: NMHI) (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture ("CEA") industry in the U.S.  The Company also engages in electric vehicle distribution and bitcoin mining. The Company has recently announced a number of initiatives to become one of the first public companies utilizing XRP digital treasury program and the related application of XRP technologies. The Company's Common Stock trades on the OTCQB market ("OTCQB") under the symbol "NMHI".

Forward-Looking Statements

The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature's Miracle's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature's Miracle's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature's Miracle's ability to develop and launch new products and services; Nature's Miracle's ability to successfully and efficiently integrate future expansion plans and opportunities; Nature's Miracle's ability to grow its business in a cost-effective manner; Nature's Miracle's product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature's Miracle's business model; developments and projections relating to Nature's Miracle's competitors and industry; and Nature's Miracle's approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the quotation of the Company's shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature's Miracle's operates; the risk that Nature's Miracle's and its current and future collaborators are unable to successfully develop and commercialize Nature's Miracle's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature's Miracle's is unable to secure or protect its intellectual property; the possibility that Nature's Miracle's may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature's Miracle's filings from time to time with the SEC.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/natures-miracle-holding-inc-nmhi-raised-2-million-through-convertible-preferred-shares-issuance-302565923.html

SOURCE Nature's Miracle Holding Inc

FAQ

How much funding did Nature's Miracle Holding (NMHI) raise in September 2025?

Nature's Miracle Holding raised $2 million through a convertible preferred shares issuance from an Asia-based private investor.

What is the conversion price for NMHI's Series D Preferred Shares?

The Series D Preferred Shares can be converted into common stock at $0.1180 per share, based on the closing price on September 18, 2025.

How will NMHI receive the $2 million investment?

The investment will be received in two tranches: $500,000 received on September 19, 2025, and $1.5 million to be closed before November 15, 2025.

What will Nature's Miracle Holding use the convertible preferred share proceeds for?

The proceeds from the convertible preferred share issuance will be used for working capital purposes.
Nature's Miracle Holding

OTC:NMHI

NMHI Rankings

NMHI Latest News

NMHI Stock Data

1.84M
10.18M
106.51%
0%
6.02%
Specialty Industrial Machinery
Farm Machinery & Equipment
Link
United States
UPLAND